Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Elos Medtech in connection with the public offer from TA Associates
Mandate

Vinge advises Elos Medtech in connection with the public offer from TA Associates

June 11, 2021 Capital Markets and Public M&A

TA Associates has announced a public offer to the shareholders of Elos Medtech AB (publ). The total value of the offer is SEK 1,735 million.

Vinge advises Elos Medtech. The Vinge team includes Erik Sjöman, Wibeke Sorling and Johanne Örnfeldt Svensson.

Related

Vinge advises Precise Biometrics in connection with rights issue
July 24, 2026

Vinge advises Summit Partners on its $1 billion-plus investment in Keyfactor

 Vinge has, together with Kirkland & Ellis, advised Summit Partners in connection with a strategic growth investment in Keyfactor, a leader in trust infrastructure. The investment will help accelerate the company's global scale and growth initiatives, enabling product innovation, geographic expansion, team building and strategic acquisitions.
July 20, 2026

Vinge has advised VAROPreem in connection with its acquisition of Sunpine

 Vinge has advised VAROPreem in connection with its acquisition of Sunpine from Sveaskog, Södra Skogsägarna and Lawter.
July 10, 2026